68 related articles for article (PubMed ID: 8833041)
1. Filgrastim (RHG-CSF) related modulation of the inflammatory response in patients at risk of sepsis or with sepsis.
Weiss M; Gross-Weege W; Harms B; Schneider EM
Cytokine; 1996 Mar; 8(3):260-5. PubMed ID: 8833041
[TBL] [Abstract][Full Text] [Related]
2. CD64 surface expression on neutrophils is transiently upregulated in patients with septic shock.
Fischer G; Schneider EM; L Moldawer LL; Karcher C; Barth E; Suger-Wiedeck H; Georgieff M; Weiss M
Intensive Care Med; 2001 Dec; 27(12):1848-52. PubMed ID: 11797018
[TBL] [Abstract][Full Text] [Related]
3. Effects of exogenous recombinant human granulocyte colony-stimulating factor (filgrastim, rhG-CSF) on neutrophils of critically ill patients with systemic inflammatory response syndrome depend on endogenous G-CSF plasma concentrations on admission.
Weiss M; Voglic S; Harms-Schirra B; Lorenz I; Lasch B; Dumon K; Gross-Weege W; Schneider EM
Intensive Care Med; 2003 Jun; 29(6):904-914. PubMed ID: 12682721
[TBL] [Abstract][Full Text] [Related]
4. Effects of repeated administration of granulocyte colony-stimulating factor (G-CSF) on neutrophil counts, plasma cytokine, and cytokine receptor levels.
Pollmächer T; Korth C; Schreiber W; Hermann D; Mullington J
Cytokine; 1996 Oct; 8(10):799-803. PubMed ID: 8980882
[TBL] [Abstract][Full Text] [Related]
5. Increase of anti-inflammatory cytokines in patients with esophageal cancer after perioperative treatment with G-CSF.
Hübel K; Mansmann G; Schäfer H; Oberhäuser F; Diehl V; Engert A
Cytokine; 2000 Dec; 12(12):1797-800. PubMed ID: 11097751
[TBL] [Abstract][Full Text] [Related]
6. Peaks of endogenous G-CSF serum concentrations are followed by an increase in respiratory burst activity of granulocytes in patients with septic shock.
Barth E; Fischer G; Schneider EM; Moldawer LL; Georgieff M; Weiss M
Cytokine; 2002 Mar; 17(5):275-84. PubMed ID: 12027409
[TBL] [Abstract][Full Text] [Related]
7. Perioperative prophylaxis with granulocyte colony-stimulating factor (G-CSF) in high-risk colorectal cancer patients for an improved recovery: A randomized, controlled trial.
Bauhofer A; Plaul U; Torossian A; Koller M; Stinner B; Celik I; Sitter H; Greger B; Middeke M; Schein M; Wyatt J; Nyström PO; Hartung T; Rothmund M; Lorenz W
Surgery; 2007 Apr; 141(4):501-10. PubMed ID: 17383527
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of neutrophil function by in vivo filgrastim treatment for prophylaxis of sepsis in surgical intensive care patients.
Weiss M; Gross-Weege W; Schneider M; Neidhardt H; Liebert S; Mirow N; Wernet P
J Crit Care; 1995 Mar; 10(1):21-6. PubMed ID: 7538851
[TBL] [Abstract][Full Text] [Related]
9. Actin polymerization in neutrophils from donors of peripheral blood stem cells: divergent effects of glycosylated and nonglycosylated recombinant human granulocyte colony-stimulating factor.
Carulli G; Mattii L; Azzarà A; Brizzi S; Galimberti S; Zucca A; Benedetti E; Petrini M
Am J Hematol; 2006 May; 81(5):318-23. PubMed ID: 16628714
[TBL] [Abstract][Full Text] [Related]
10. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
[TBL] [Abstract][Full Text] [Related]
11. Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis.
Root RK; Lodato RF; Patrick W; Cade JF; Fotheringham N; Milwee S; Vincent JL; Torres A; Rello J; Nelson S;
Crit Care Med; 2003 Feb; 31(2):367-73. PubMed ID: 12576938
[TBL] [Abstract][Full Text] [Related]
12. Systemic inflammatory response to exhaustive exercise. Cytokine kinetics.
Suzuki K; Nakaji S; Yamada M; Totsuka M; Sato K; Sugawara K
Exerc Immunol Rev; 2002; 8():6-48. PubMed ID: 12690937
[TBL] [Abstract][Full Text] [Related]
13. Effect of filgrastim treatment on inflammatory cytokines and lymphocyte functions.
Hartung T; Doecke WD; Bundschuh D; Foote MA; Gantner F; Hermann C; Lenz A; Milwee S; Rich B; Simon B; Volk HD; von Aulock S; Wendel A
Clin Pharmacol Ther; 1999 Oct; 66(4):415-24. PubMed ID: 10546926
[TBL] [Abstract][Full Text] [Related]
14. Mobilization of peripheral blood stem cells following myelosuppressive chemotherapy: a randomized comparison of filgrastim, sargramostim, or sequential sargramostim and filgrastim.
Weaver CH; Schulman KA; Buckner CD
Bone Marrow Transplant; 2001 May; 27 Suppl 2():S23-9. PubMed ID: 11436117
[TBL] [Abstract][Full Text] [Related]
15. Differences in the expression of CD64 and mCD14 on polymorphonuclear cells and on monocytes in patients with septic shock.
Barth E; Fischer G; Schneider EM; Wollmeyer J; Georgieff M; Weiss M
Cytokine; 2001 Jun; 14(5):299-302. PubMed ID: 11444911
[TBL] [Abstract][Full Text] [Related]
16. Treatment with granulocyte colony-stimulating factor increases interleukin-1 receptor antagonist levels during engraftment following allogeneic stem-cell transplantation.
Schwabe M; Hartert AM; Bertz H; Finke J
Eur J Clin Invest; 2004 Nov; 34(11):759-65. PubMed ID: 15530149
[TBL] [Abstract][Full Text] [Related]
17. Differences in functional activity and antigen expression of granulocytes primed in vivo with filgrastim, lenograstim, or pegfilgrastim.
Ribeiro D; Veldwijk MR; Benner A; Laufs S; Wenz F; Ho AD; Fruehauf S
Transfusion; 2007 Jun; 47(6):969-80. PubMed ID: 17524085
[TBL] [Abstract][Full Text] [Related]
18. Cytokine and cytokine receptor serum levels in adult bone sarcoma patients: correlations with local tumor extent and prognosis.
Rutkowski P; Kamińska J; Kowalska M; Ruka W; Steffen J
J Surg Oncol; 2003 Nov; 84(3):151-9. PubMed ID: 14598359
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: comparison with single and multiple daily doses of filgrastim.
van Der Auwera P; Platzer E; Xu ZX; Schulz R; Feugeas O; Capdeville R; Edwards DJ
Am J Hematol; 2001 Apr; 66(4):245-51. PubMed ID: 11279634
[TBL] [Abstract][Full Text] [Related]
20. Regulation of Toll-like receptor (TLR)2 and TLR4 on CD14dimCD16+ monocytes in response to sepsis-related antigens.
Skinner NA; MacIsaac CM; Hamilton JA; Visvanathan K
Clin Exp Immunol; 2005 Aug; 141(2):270-8. PubMed ID: 15996191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
